SCHEMBL873463

SCHEMBL873463

CCCC=CCOC(=O)CC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.42
TSHR P16473 2/20 0.36
ALDH1A1 P00352 4/20 0.36
CYP1A2 P05177 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
BLM P54132 1/20 0.34
WRN Q14191 1/20 0.34
HIF1A Q16665 1/20 0.34
PTGS1 P23219 1/20 0.34
NR1I2 O75469 1/20 0.34
PGR P06401 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
PTGS2 P35354 1/20 0.34
PDE4D Q08499 1/20 0.34
MGLL Q99685 1/20 0.34
FAAH O00519 3/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
CNR1 P21554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL873462 1.00 NAAA (0.42) NAAATSHRALDH1A1CYP1A2HPGD
SCHEMBL2039597 1.00 NAAA (0.42) NAAATSHRALDH1A1CYP1A2HPGD
Propionic Acid SCHEMBL1868934 0.94 PTGS1 (0.39) NAAACYP1A2CYP2C19BLMPTGS1
SCHEMBL11292223 0.89 NAAA (0.44) NAAATSHRALDH1A1CYP1A2HPGD
SCHEMBL8744192 0.89 NAAA (0.44) NAAATSHRALDH1A1CYP1A2HPGD
SCHEMBL8744195 0.89 NAAA (0.44) NAAATSHRALDH1A1CYP1A2HPGD
SCHEMBL8961915 0.88 NAAA (0.48) NAAATSHRALDH1A1CYP1A2CYP2C19
Crotonic Acid SCHEMBL28250370 0.88 HCAR2 (0.37) NAAATSHRPTGS1TAS1R3TAS1R1
SCHEMBL20872361 0.87 MGAM (0.46) TSHRALDH1A1PTGS1NR1I2PGR
SCHEMBL5991172 0.86 NAAA (0.52) NAAAALDH1A1CYP1A2CYP2C19BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3309245-A1 ENCAPSULATES The Procter & Gamble Company (US) 2018-04-18 EP claimed
EP-2512406-B1 PERFUMES AND PERFUME ENCAPSULATES PROCTER & GAMBLE (US) 2018-01-24 EP claimed
EP-2512406-A1 PERFUMES AND PERFUME ENCAPSULATES The Procter & Gamble Company (US) 2012-10-24 EP claimed
EP-2513280-A1 COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM The Procter & Gamble Company (US) 2012-10-24 EP claimed
WO-2011075551-A1 PERFUMES AND PERFUME ENCAPSULATES THE PROCTER & GAMBLE COMPANY (US) 2011-06-23 WO claimed
US-20030036489-A1 Consumable composition comprising perfumed particles and article containing the same THE PROCTER & GAMBLE COMPANY 2003-02-20 US claimed
WO-2002090479-A1 PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME THE PROCTER & GAMBLE COMPANY (US) 2002-11-14 WO claimed
WO-2002090481-A1 COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME THE PROCTER & GAMBLE COMPANY (US) 2002-11-14 WO claimed
EP-4435080-B1 A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE PROCTER & GAMBLE (US) 2025-08-20 EP disclosed
US-12371642-B2 Benefit agent containing delivery particle THE PROCTER & GAMBLE COMPANY (US) 2025-07-29 US disclosed
EP-3955900-B1 POLYMERIC CAPSULES PROCTER & GAMBLE (US) 2025-07-23 EP disclosed
WO-2025056470-A1 AQUEOUS-BASED PERFUME COMPOSITION JAFER ENTERPRISES R&D SL (ES) 2025-03-20 WO disclosed
WO-2024213455-A1 USE OF A COMPOSITION, IN PARTICULAR A FRAGRANCING COMPOSITION, COMPRISING DIETHYL SUCCINATE AND A TERTIARY AMINE JAFER ENTERPRISES R&D SL. (ES) 2024-10-17 WO disclosed
US-20240316523-A1 PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE PROCTER & GAMBLE COMPANY, THE 2024-09-26 US disclosed
WO-2002089862-A2 AIR FRESHENING COMPOSITIONS, ARTICLES COMPRISING SAME AND METHODS FOR PREPARING SAME THE PROCTER & GAMBLE COMPANY (US) 2002-11-14 WO disclosed
WO-2002090479-A1 PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME THE PROCTER & GAMBLE COMPANY (US) 2002-11-14 WO disclosed
WO-2002090480-A1 DRYER-ADDED FABRIC SOFTENING ARTICLES AND METHODS THE PROCTER & GAMBLE COMPANY (US) 2002-11-14 WO disclosed
US-20020055455-A1 Use of unsaturated esters as perfuming ingredients FIRMENICH SA (CH) 2002-05-09 US disclosed
EP-1188433-A2 Use of unsaturated esters as perfuming ingredients FIRMENICH SA (CH) 2002-03-20 EP disclosed
CN-1163260-A Process for preparing pure alkyl acetate alkyl ester LONZA AG (CH) 1997-10-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020055455-A1 Use of unsaturated esters as perfuming ingredients CYP2E1, ELOVL1, ELOVL5 NAAA 1483/4885TSHR 4410/4885ALDH1A1 744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.